Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LIFE

aTyr Pharma (LIFE) Stock Price, News & Analysis

aTyr Pharma logo

About aTyr Pharma Stock (NASDAQ:LIFE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.57
$2.07
52-Week Range
N/A
Volume
269,400 shs
Average Volume
514,103 shs
Market Capitalization
$131.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LIFE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for aTyr Pharma and its competitors with MarketBeat's FREE daily newsletter.

LIFE Stock News Headlines

aTyr: Promising Data, But Cash May Be An Issue
The DOJ Just Paved the Way for Account Seizures
Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.
Is aTyr Pharma (ATYR) The Hot Biotech Stock Under $5?
aTyr Pharma (ATYR) Receives a Buy from Wells Fargo
See More Headlines

LIFE Stock Analysis - Frequently Asked Questions

aTyr Pharma, Inc. (NASDAQ:LIFE) released its quarterly earnings data on Thursday, May, 2nd. The biotechnology company reported ($0.23) EPS for the quarter, topping analysts' consensus estimates of ($0.24) by $0.01. The biotechnology company had revenue of $0.24 million for the quarter, compared to analysts' expectations of $0.11 million.

Shares of aTyr Pharma reverse split before market open on Monday, July 1st 2019.The 1-14 reverse split was announced on Friday, June 28th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 28th 2019. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

aTyr Pharma (LIFE) raised $76 million in an IPO on Thursday, May 7th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Citigroup served as the underwriters for the IPO and BMO Capital Markets and William Blair were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that aTyr Pharma investors own include Tesla (TSLA), Plug Power (PLUG), Meta Platforms (META), NVIDIA (NVDA), SCYNEXIS (SCYX), Ford Motor (F) and NIO (NIO).

Company Calendar

Last Earnings
5/02/2024
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:LIFE
CIK
1339970
Employees
56
Year Founded
2005

Profitability

EPS (Trailing Twelve Months)
($0.90)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.39 million
Net Margins
N/A
Pretax Margin
-9,172.11%
Return on Equity
-56.92%
Return on Assets
-43.87%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
6.07
Quick Ratio
6.07

Sales & Book Value

Annual Sales
$350 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.54 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
69,010,000
Free Float
66,458,000
Market Cap
$131.12 million
Optionable
Optionable
Beta
1.19

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:LIFE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners